Antimicrobial Catheter Market Growth Accelerated by Increased Adoption of Urinary Catheters

 

Antimicrobial Catheter Market 

Catheters are medical tubes that are inserted into the body to drain fluids from or infuse substances into the body. Antimicrobial catheters have antimicrobial agents that help prevent the risk of catheter-associated urinary tract infections (CAUTIs). CAUTIs occur in 5-10% of patients with an indwelling urinary catheter and are the most common healthcare-associated infection. The growing geriatric population and increasing number of surgical procedures are enhancing the risk of healthcare associated infections, thereby driving the demand for antimicrobial catheters.

 

The global antimicrobial catheter market is estimated to be valued at US$ 14505.18 Mn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

 

Market Dynamics:

One of the major drivers of the antimicrobial catheter market growth is the rising prevalence of hospital acquired infections. Hospital acquired infections, also known as nosocomial infections, are those infections that patients acquire during the course of treatment for other conditions within a healthcare setting. It is estimated that over 5% of patients in developed countries and 15% of patients in developing countries acquire at least one nosocomial infection. Catheter-associated urinary tract infections are one of the most common types of hospital acquired infections. The risk of CAUTIs can be significantly reduced with the use of antimicrobial catheters. Another driver propelling the market growth is the increasing surgical procedures that require catheter placements. With the rising obese population undergoing bariatric surgeries and number of orthopedic and cardiovascular procedures, the demand for antimicrobial catheters is growing substantially.

 

SWOT Analysis

Strength: Antimicrobial catheters help prevent catheter-associated urinary tract infections (CAUTIs), one of the most common hospital-acquired infections. By inhibiting the growth and colonization of microbes on the catheter, they significantly reduce infection risks for patients. Early detection and prevention of infections also helps lower healthcare costs.

 

Weakness: Traditional antimicrobial coatings like silver and antibiotics have issues with resistance development over time. Microbes keep evolving defenses against such mechanisms. Some coatings also interact adversely with other medical devices or drugs. Limited efficacy periods require frequent catheter changes.

 

Opportunity: Promising new technologies using probiotics, biofilms, and phages offer more targeted and durable infection prevention without resistance concerns. Live bacterial interference and synergies between different protective mechanisms show high potential. Developing economies and aging populations will drive greater demand for safer long-term catheterization solutions.

 

Threats: Stringent regulatory compliances delay market approvals and increase costs. Access to clinical trial subjects and funding challenges hinder research. Commoditization of commodity coatings increases price pressures on suppliers. Shift towards non-catheter alternatives and intermittent catheterization where feasible also impacts sales opportunities.

 

Key Takeaways

The Global Antimicrobial Catheter Market Size is expected to witness high growth over the forecast period of 2024 to 2031 supported by increasing prevalence of hospital-acquired infections, growing aging population undergoing long-term catheterization, and advancements in technologies. The market size is projected to reach US$ 14505.18 Mn by 2031 from US$ 8154.53 Mn in 2024, registering a CAGR of 11% during the forecast period.

 

Regional analysis: North America currently dominates the market owing to the large patient pool undergoing catheter-related procedures, rising healthcare expenditure, stringent hospital safety regulations, and presence of leading market players. However, Asia Pacific is likely to emerge as the fastest growing regional market supported by improving access to healthcare infrastructures and services across developing nations, and increasing focus on preventing device-associated infections.

 

Key players: Key players operating in the antimicrobial catheter market are Pendulum, Amsterdam Winclove Probiotics, Metabogen AB (Biogaia), Exeliom Biosciences, TargEDys, Chr. Hansen Holding A/S, YSOPIA Bioscience, A-Mansia Biotech, Next Gen Probiotics, Evolve Biosystems and DuPont de Nemours, Inc. Companies are focused on introducing novel surfaces and coating technologies leveraging probiotics, biofilms and phages to provide durable and resistance-proof infection prevention solutions.


Get More Insights Here

https://masstamilan.tv/industrial-dryers-advancing-process-efficiency-in-manufacturing-industries/

https://www.newsanalyticspro.com/antimicrobial-catheter-market-size-share-growth-outlook-2023/

Comments

Popular posts from this blog

Global Veterinary Equipment and Disposables Market: Trends and Outlook

"Vaginal Slings Market: A Comprehensive Analysis of Growth Trends and Opportunities"

The Global Stem Cell Banking Market is Anticipated to Witness Considerable Growth Due to Rising Awareness About Stem Cell Therapies